The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20
Tjeerd J. Postma(Amsterdam UMC Location Vrije Universiteit Amsterdam), R. Lucey(Mount Vernon Hospital), Michel Lantéri‐Minet(Inserm), Mirte Muller(The Netherlands Cancer Institute), Robert Huddart(Institute of Cancer Research), Clare Moynihan(Royal Marsden NHS Foundation Trust), Robin Grant(Western General Hospital), Neil K. Aaronson(The Netherlands Cancer Institute), Jan J. Heimans(Amsterdam UMC Location VUmc), J.‐Y. Delattre(Pitié-Salpêtrière Hospital), Khê Hoang‐Xuan(Sorbonne Université), Jerzy Hildebrand(Erasmus Hospital), JaneMaree Maher(Monash University)
Cited by 576
Related Papers
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
|Journal of Clinical Epidemiology|1998|2.9k
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations
|Journal of Clinical Epidemiology|1998|2.3k
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k